126 related articles for article (PubMed ID: 33408831)
1. Successful treatment of progressive macular hypomelanosis.
Leonard N; Krueger S; Rashighi M
Dermatol Reports; 2020 Sep; 12(2):8509. PubMed ID: 33408831
[TBL] [Abstract][Full Text] [Related]
2. Progressive macular hypomelanosis, excellent response with narrow-band ultraviolet B phototherapy.
Montero LC; Belinchón I; Toledo F; Betlloch I
Photodermatol Photoimmunol Photomed; 2011 Jun; 27(3):162-3. PubMed ID: 21535172
[TBL] [Abstract][Full Text] [Related]
3. Progressive macular hypomelanosis: an overview.
Relyveld GN; Menke HE; Westerhof W
Am J Clin Dermatol; 2007; 8(1):13-9. PubMed ID: 17298102
[TBL] [Abstract][Full Text] [Related]
4. Progressive macular hypomelanosis: an epidemiological study and therapeutic response to phototherapy.
Duarte I; Nina BI; Gordiano MC; Buense R; Lazzarini R
An Bras Dermatol; 2010; 85(5):621-4. PubMed ID: 21152785
[TBL] [Abstract][Full Text] [Related]
5. Benzoyl peroxide/clindamycin/UVA is more effective than fluticasone/UVA in progressive macular hypomelanosis: a randomized study.
Relyveld GN; Kingswijk MM; Reitsma JB; Menke HE; Bos JD; Westerhof W
J Am Acad Dermatol; 2006 Nov; 55(5):836-43. PubMed ID: 17052490
[TBL] [Abstract][Full Text] [Related]
6. Narrowband UVB treatment of progressive macular hypomelanosis.
Kim MB; Kim GW; Cho HH; Park HJ; Kim HS; Kim SH; Kim BS; Ko HC
J Am Acad Dermatol; 2012 Apr; 66(4):598-605. PubMed ID: 22005073
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of topical combination of benzoyl peroxide 5% and clindamycin 1% for the treatment of progressive macular hypomelanosis: a randomized, doubleblind, placebo-controlled trial.
Santos JB; Almeida OL; Silva LM; Barreto ER
An Bras Dermatol; 2011; 86(1):50-4. PubMed ID: 21437522
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and relapse rates of different treatment modalities for progressive macular hypomelanosis.
Thng ST; Long VS; Chuah SY; Tan VW
Indian J Dermatol Venereol Leprol; 2016; 82(6):673-676. PubMed ID: 27212282
[TBL] [Abstract][Full Text] [Related]
9. Progressive macular hypomelanosis arising in a young African American woman in association with pregnancy and a toxic nodular goiter.
Tierney EP; Hamzavi I
J Drugs Dermatol; 2010 Apr; 9(4):393-7. PubMed ID: 20514800
[TBL] [Abstract][Full Text] [Related]
10. Progressive macular hypomelanosis in korean patients: a clinicopathologic study.
Hwang SW; Hong SK; Kim SH; Park JH; Seo JK; Sung HS; Lee D
Ann Dermatol; 2009 Aug; 21(3):261-7. PubMed ID: 20523800
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the clinical efficacy of NBUVB and NBUVB with benzoyl peroxide/clindamycin in progressive macular hypomelanosis.
Sim JH; Lee DJ; Lee JS; Kim YC
J Eur Acad Dermatol Venereol; 2011 Nov; 25(11):1318-23. PubMed ID: 21349111
[TBL] [Abstract][Full Text] [Related]
12. Progressive macular hypomelanosis.
Elmariah SB; Kundu RV
J Drugs Dermatol; 2011 May; 10(5):502-6. PubMed ID: 21533296
[TBL] [Abstract][Full Text] [Related]
13. Progressive macular hypomelanosis among Egyptian patients: a clinicopathological study.
Selim MK; Ahmed el-SF; Abdelgawad MM; El-Kamel MF
Dermatol Pract Concept; 2011; 1(1):5-11. PubMed ID: 24396712
[TBL] [Abstract][Full Text] [Related]
14. Treatment of progressive macular hypomelanosis with narrow-band ultraviolet B phototherapy.
Kwah YC; Chong WS; Thiam-Seng Theng C; Goh BK
Photodermatol Photoimmunol Photomed; 2010 Jun; 26(3):153-5. PubMed ID: 20584255
[TBL] [Abstract][Full Text] [Related]
15. [Progressive macular hypomelanosis successfully treated with topical clindamycin and benzoyl peroxide].
Echeverría B; Botella-Estrada R; Escutia B; Guillén C
Actas Dermosifiliogr; 2010 Jul; 101(6):565-7. PubMed ID: 20738984
[No Abstract] [Full Text] [Related]
16. Facial involvement in progressive macular hypomelanosis.
Wang K; Nassef Y; Sahu J; Hermes H; Schwartz LR
Cutis; 2018 Apr; 101(4):297-300. PubMed ID: 29763479
[TBL] [Abstract][Full Text] [Related]
17. Progressive macular hypomelanosis.
Martínez-Martínez ML; Azaña-Defez JM; Rodríguez-Vázquez M; Faura-Berruga C; Escario-Travesedo E
Pediatr Dermatol; 2012; 29(4):460-2. PubMed ID: 21995551
[TBL] [Abstract][Full Text] [Related]
18. Progressive macular hypomelanosis: a rarely diagnosed hypopigmentation in Caucasians.
Neynaber S; Kirschner C; Kamann S; Plewig G; Flaig MJ
Dermatol Res Pract; 2009; 2009():607682. PubMed ID: 20585481
[TBL] [Abstract][Full Text] [Related]
19. A case of progressive macular hypomelanosis treated with 1% topical clindamycin lotion and narrow-band ultraviolet B.
Erpolat S; Gorpelioglu C; Sarifakioglu E
Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):277-8. PubMed ID: 20831700
[No Abstract] [Full Text] [Related]
20. Successful Treatment of Vitiligo Vietnamese Patients with Vitilinex® Herbal Bio-Actives in Combination with Phototherapy.
Van TN; Minh TT; Huu DL; Huu SN; Thanh TV; Huu ND; Cam VT; Huyen ML; Hau KT; Trong HN; Gandolfi M; Satolli F; Feliciani C; Tirant M; Vojvodic A; Lotti T
Open Access Maced J Med Sci; 2019 Jan; 7(2):283-286. PubMed ID: 30745981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
